Sign In to Follow Application
View All Documents & Correspondence

Glycine Compound

Abstract: The present invention provides a compound which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases. [Means for Solution] The present inventors have conducted intensive studies on a compound having a VAP-1 inhibitory activity, and as a result, they have found that a compound of the present invention or a salt thereof exhibits an excellent VAP-1 inhibitory activity and is useful for preventing and/or treating VAP-1-related diseases, in particular, diabetic nephropathy or diabetic macular edema, thereby completing the present invention. The present invention further relates to a pharmaceutical composition, in particular, a pharmaceutical composition for preventing and/or treating VAP-1-related diseases, which comprises the compound of the present invention or a salt thereof, and an excipient. [Selected Figure] Nil

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
16 March 2012
Publication Number
22/2013
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
patent@depenning.com
Parent Application

Applicants

ASTELLAS PHARMA INC.
3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO-103-8411

Inventors

1. YOSHIHARA, KOUSEI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411
2. SUZUKI, DAISUKE
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411
3. YAMAKI, SUSUMU
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411
4. KOGA, YUJI
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411
5. SEKI, NORIO
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411
6. FUJIYASU, JIRO
C/O ASTELLAS PHARMA INC., 3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO 103-8411

Specification

Documents

Application Documents

# Name Date
1 2472-CHENP-2012 POWER OF ATTORNEY 16-03-2012.pdf 2012-03-16
1 2472-CHENP-2012-AbandonedLetter.pdf 2018-06-22
2 2472-CHENP-2012 FORM-2 16-03-2012.pdf 2012-03-16
2 2472-CHENP-2012-FER.pdf 2017-12-12
3 2472-CHENP-2012 DESCRIPTION(COMPLETE)-3 16-03-2012.pdf 2012-03-16
3 2472-CHENP-2012 CORRESPONDENCE OTHERS 08-09-2014.pdf 2014-09-08
4 2472-CHENP-2012 FORM-3 08-09-2014.pdf 2014-09-08
4 2472-CHENP-2012 DESCRIPTION(COMPLETE)-2 16-03-2012.pdf 2012-03-16
5 2472-CHENP-2012 DESCRIPTION(COMPLETE)-1 16-03-2012.pdf 2012-03-16
5 2472-CHENP-2012 FORM-13 06-09-2013.pdf 2013-09-06
6 2472-CHENP-2012 DESCRIPTION(COMPLETE) 16-03-2012.pdf 2012-03-16
6 2472-CHENP-2012 AMENDED CLAIMS 06-09-2013.pdf 2013-09-06
7 2472-CHENP-2012 CLAIMS 16-03-2012.pdf 2012-03-16
7 2472-CHENP-2012 AMENDED PAGES OF SPECIFICATION 06-09-2013.pdf 2013-09-06
8 2472-CHENP-2012 CORRESPONDENCE OTHERS 06-09-2013.pdf 2013-09-06
8 2472-CHENP-2012 ABSTRACT 16-03-2012.pdf 2012-03-16
9 2472-CHENP-2012 PCT 16-03-2012..pdf 2012-03-16
9 2472-CHENP-2012 FORM-18 06-09-2013.pdf 2013-09-06
10 2472-CHENP-2012 FORM-5 16-03-2012..pdf 2012-03-16
10 2472-CHENP-2012 CORRESPONDENCE OTHERS 19-06-2013.pdf 2013-06-19
11 2472-CHENP-2012 CORRESPONDENCE OTHERS 12-09-2012.pdf 2012-09-12
11 2472-CHENP-2012 FORM-3 16-03-2012..pdf 2012-03-16
12 2472-CHENP-2012 FORM-1 16-03-2012..pdf 2012-03-16
12 2472-CHENP-2012 FORM-3 12-09-2012.pdf 2012-09-12
13 2472-CHENP-2012 CORRESPONDENCE OTHERS 16-03-2012..pdf 2012-03-16
13 2472-CHENP-2012 AMENDED CLAIMS 29-06-2012.pdf 2012-06-29
14 2472-CHENP-2012 FORM-13 29-06-2012.pdf 2012-06-29
14 2472-CHENP-2012 FORM-5 08-05-2012..pdf 2012-05-08
15 2472-CHENP-2012 CORRESPONDENCE OTHERS 29-06-2012.pdf 2012-06-29
15 2472-CHENP-2012 FORM-13 08-05-2012.pdf 2012-05-08
16 2472-CHENP-2012 ENGLISH TRANSLATION 27-06-2012.pdf 2012-06-27
16 2472-CHENP-2012 FORM-1 08-05-2012..pdf 2012-05-08
17 2472-CHENP-2012 CORRESPONDENCE OTHERS 08-05-2012..pdf 2012-05-08
17 2472-CHENP-2012 CORRESPONDENCE OTHERS 27-06-2012.pdf 2012-06-27
18 2472-CHENP-2012 FORM-13 27-06-2012.pdf 2012-06-27
19 2472-CHENP-2012 CORRESPONDENCE OTHERS 27-06-2012.pdf 2012-06-27
19 2472-CHENP-2012 CORRESPONDENCE OTHERS 08-05-2012..pdf 2012-05-08
20 2472-CHENP-2012 ENGLISH TRANSLATION 27-06-2012.pdf 2012-06-27
20 2472-CHENP-2012 FORM-1 08-05-2012..pdf 2012-05-08
21 2472-CHENP-2012 CORRESPONDENCE OTHERS 29-06-2012.pdf 2012-06-29
21 2472-CHENP-2012 FORM-13 08-05-2012.pdf 2012-05-08
22 2472-CHENP-2012 FORM-13 29-06-2012.pdf 2012-06-29
22 2472-CHENP-2012 FORM-5 08-05-2012..pdf 2012-05-08
23 2472-CHENP-2012 CORRESPONDENCE OTHERS 16-03-2012..pdf 2012-03-16
23 2472-CHENP-2012 AMENDED CLAIMS 29-06-2012.pdf 2012-06-29
24 2472-CHENP-2012 FORM-3 12-09-2012.pdf 2012-09-12
24 2472-CHENP-2012 FORM-1 16-03-2012..pdf 2012-03-16
25 2472-CHENP-2012 CORRESPONDENCE OTHERS 12-09-2012.pdf 2012-09-12
25 2472-CHENP-2012 FORM-3 16-03-2012..pdf 2012-03-16
26 2472-CHENP-2012 FORM-5 16-03-2012..pdf 2012-03-16
26 2472-CHENP-2012 CORRESPONDENCE OTHERS 19-06-2013.pdf 2013-06-19
27 2472-CHENP-2012 PCT 16-03-2012..pdf 2012-03-16
27 2472-CHENP-2012 FORM-18 06-09-2013.pdf 2013-09-06
28 2472-CHENP-2012 ABSTRACT 16-03-2012.pdf 2012-03-16
28 2472-CHENP-2012 CORRESPONDENCE OTHERS 06-09-2013.pdf 2013-09-06
29 2472-CHENP-2012 AMENDED PAGES OF SPECIFICATION 06-09-2013.pdf 2013-09-06
29 2472-CHENP-2012 CLAIMS 16-03-2012.pdf 2012-03-16
30 2472-CHENP-2012 AMENDED CLAIMS 06-09-2013.pdf 2013-09-06
30 2472-CHENP-2012 DESCRIPTION(COMPLETE) 16-03-2012.pdf 2012-03-16
31 2472-CHENP-2012 DESCRIPTION(COMPLETE)-1 16-03-2012.pdf 2012-03-16
31 2472-CHENP-2012 FORM-13 06-09-2013.pdf 2013-09-06
32 2472-CHENP-2012 FORM-3 08-09-2014.pdf 2014-09-08
32 2472-CHENP-2012 DESCRIPTION(COMPLETE)-2 16-03-2012.pdf 2012-03-16
33 2472-CHENP-2012 DESCRIPTION(COMPLETE)-3 16-03-2012.pdf 2012-03-16
33 2472-CHENP-2012 CORRESPONDENCE OTHERS 08-09-2014.pdf 2014-09-08
34 2472-CHENP-2012-FER.pdf 2017-12-12
34 2472-CHENP-2012 FORM-2 16-03-2012.pdf 2012-03-16
35 2472-CHENP-2012-AbandonedLetter.pdf 2018-06-22
35 2472-CHENP-2012 POWER OF ATTORNEY 16-03-2012.pdf 2012-03-16

Search Strategy

1 2472_CHENP_2012_14-11-2017.pdf